NATUS MEDICAL INC Cashflow Statement

Ask AI

Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements of Cash Flows

In millions of USD, except per-share amounts

	FY2021 12 months to Dec 31, 2021	FY2020 12 months to Dec 31, 2020	FY2019 12 months to Dec 31, 2019	FY2018 12 months to Dec 31, 2018	FY2017 12 months to Dec 31, 2017
Operating activities:
Net loss
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
Provision for losses on accounts receivable
Depreciation and amortization
Sales-type Lease, Selling Profit (Loss)
Loss on equity method investment adjustment
(Gain) Loss on disposal of property and equipment
Impairment of intangible assets
Impairment, Long-Lived Asset, Held-for-Use
Impairment charge for sale of entity
Goodwill impairment charge
Warranty reserve
Stock-based compensation
Non cash lease expense
Deferred taxes
Changes in operating assets and liabilities, net of assets and liabilities acquired in acquisitions:
Accounts receivable
Inventories
Other assets
Accounts payable
Accrued liabilities
Deferred revenue
Net cash provided by operating activities
Investing activities:
Acquisition of businesses, net of cash acquired
Acquisition of property and equipment
Acquisition of intangible assets
Purchases of short-term investments
Sales of short-term investments
Proceeds from Sale of Property, Plant, and Equipment
Purchases of equity investments
Net cash used in investing activities

Financing activities:
Proceeds from stock option exercises and ESPP
Excess tax benefit on the exercise of stock options
Finance Lease, Principal Payments
Repurchase of company stock
Taxes paid related to net share settlement of equity awards
Proceeds from short-term borrowings
Proceeds from long-term borrowings
Deferred debt issuance costs
Contingent consideration earn-out
Payments on borrowings
Net cash used in financing activities

Exchange rate effect on cash and cash equivalents
Net increase (decrease) in cash and cash equivalents
Cash and cash equivalents, beginning of year
Cash and cash equivalents, end of year
Supplemental disclosure of cash flow information:
Cash paid for interest
Cash paid for income taxes
Non-cash investing activities:
Property and equipment included in accounts payable
Inventory transferred to property and equipment
Transfer of leased assets to sales-type leases

Comments